Real-world clinical experience with idebenone in the treatment of Leber hereditary optic neuropathy

<br><strong>Background: </strong> Leber hereditary optic neuropathy (LHON) leads to bilateral central vision loss. In a clinical trial setting, idebenone has been shown to be safe and to provide a trend toward improved visual acuity, but long-term evidence of effectiveness in real-...

Full description

Bibliographic Details
Main Authors:	Catarino, CB, von Livonius, B, Priglinger, C, Banik, R, Matloob, S, Tamhankar, MA, Castillo, L, Friedburg, C, Halfpenny, CA, Lincoln, JA, Traber, GL, Acaroglu, G, Black, GCM, Doncel, C, Fraser, CL, Jakubaszko, J, Landau, K, Langenegger, SJ, Muñoz-Negrete, FJ, Newman, NJ, Poulton, J, Scoppettuolo, E, Subramanian, P, Toosy, AT, Vidal, M, Vincent, AL, Votruba, M, Zarowski, M, Zermansky, A, Lob, F, Rudolph, G, Mikazans, O, Silva, M, Llòria, X, Metz, G, Klopstock, T
Format:	Journal article
Language:	English
Published:	Wolters Kluwer Health 2020

Real-world clinical experience with idebenone in the treatment of Leber hereditary optic neuropathy

Similar Items